openPR Logo
Press release

Ocular Inflammation and Pain Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Visiox Pharma LLC, Sun Pharma/InSite Vision, Formosa Pharmaceuticals, Inc., Surface Pharmaceuticals, Inc.

07-19-2023 02:17 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Ocular Inflammation and Pain Market Report 2032: Epidemiology

DelveInsight's "Ocular Inflammation and Pain Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Ocular Inflammation and Pain, historical and forecasted epidemiology as well as the Ocular Inflammation and Pain market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Ocular Inflammation and Pain market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Ocular Inflammation and Pain Market Forecast
https://www.delveinsight.com/sample-request/ocular-inflammation-and-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Ocular Inflammation and Pain Market Report:
• The Ocular Inflammation and Pain market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In a population-based study conducted in the US, 2482 participants between the ages of 65 and 84 were asked how often they experienced dryness, grittiness, and burning
• According to Majid et al. (2022), more women than men have ocular neuropathic pain. Associated diseases including fibromyalgia and autoimmune disorders are also more common in women
• Key Ocular Inflammation and Pain Companies: Visiox Pharma LLC, Sun Pharma/InSite Vision, Formosa Pharmaceuticals, Inc., Surface Pharmaceuticals, Inc., Tarsier Pharma, Ocular Therapeutix, Inc., Kala Pharmaceuticals, Inc., Laboratorios Sophia S.A de C.V., Xigen SA, and others
• Key Ocular Inflammation and Pain Therapies: SDN-037, DexaSite (ISV-305) , APP13007, SURF-201, TRS01, OTX-DP (Dexamethasone punctum plug), KPI-121, PRO-155, Dexamethasone, XG-102, and others
• The Ocular Inflammation and Pain epidemiology based on gender analyzed that it can be concluded that ocular inflammation and pain affects females mostly than the males
• The Ocular Inflammation and Pain market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Ocular Inflammation and Pain pipeline products will significantly revolutionize the Ocular Inflammation and Pain market dynamics.

Ocular Inflammation and Pain Overview
Infections, allergies, autoimmune diseases, irritation, injuries, or damage to the eyes, eyelids, or surrounding tissues can cause eye inflammation. Depending on the source of the inflammation, different areas of the eye may be impacted.

Get a Free sample for the Ocular Inflammation and Pain Market Report
https://www.delveinsight.com/report-store/ocular-inflammation-and-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Ocular Inflammation and Pain Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Ocular Inflammation and Pain Epidemiology Segmentation:
The Ocular Inflammation and Pain market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Ocular Inflammation and Pain
• Prevalent Cases of Ocular Inflammation and Pain by severity
• Gender-specific Prevalence of Ocular Inflammation and Pain
• Diagnosed Cases of Episodic and Chronic Ocular Inflammation and Pain

Download the report to understand which factors are driving Ocular Inflammation and Pain epidemiology trends @ Ocular Inflammation and Pain Epidemiology Forecast
https://www.delveinsight.com/sample-request/ocular-inflammation-and-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Ocular Inflammation and Pain Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Ocular Inflammation and Pain market or expected to get launched during the study period. The analysis covers Ocular Inflammation and Pain market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Ocular Inflammation and Pain Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Ocular Inflammation and Pain Therapies and Key Companies
• SDN-037: Visiox Pharma LLC
• DexaSite (ISV-305): Sun Pharma/InSite Vision
• APP13007: Formosa Pharmaceuticals, Inc.
• SURF-201: Surface Pharmaceuticals, Inc.
• TRS01: Tarsier Pharma
• APP13007: Formosa Pharmaceuticals, Inc.
• OTX-DP (Dexamethasone punctum plug): Ocular Therapeutix, Inc.
• KPI-121: Kala Pharmaceuticals, Inc.
• PRO-155: Laboratorios Sophia S.A de C.V.
• Dexamethasone: Ocular Therapeutix, Inc.
• XG-102: Xigen SA

Discover more about therapies set to grab major Ocular Inflammation and Pain market share @ Ocular Inflammation and Pain Treatment Market
https://www.delveinsight.com/sample-request/ocular-inflammation-and-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Ocular Inflammation and Pain Market Drivers
• The introduction of biologics such as adalimumab
• Rich emerging pipeline for the treatment of various symptoms of ocular inflammation and pain.

Ocular Inflammation and Pain Market Barriers
• Challenges in diagnoses
• Development of novel therapies
• Limitations in gene therapy
• Poor disease understanding
• Lack of treatment options

Scope of the Ocular Inflammation and Pain Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Ocular Inflammation and Pain Companies: Visiox Pharma LLC, Sun Pharma/InSite Vision, Formosa Pharmaceuticals, Inc., Surface Pharmaceuticals, Inc., Tarsier Pharma, Ocular Therapeutix, Inc., Kala Pharmaceuticals, Inc., Laboratorios Sophia S.A de C.V., Xigen SA, and others
• Key Ocular Inflammation and Pain Therapies: SDN-037, DexaSite (ISV-305) , APP13007, SURF-201, TRS01, OTX-DP (Dexamethasone punctum plug), KPI-121, PRO-155, Dexamethasone, XG-102, and others
• Ocular Inflammation and Pain Therapeutic Assessment: Ocular Inflammation and Pain current marketed and Ocular Inflammation and Pain emerging therapies
• Ocular Inflammation and Pain Market Dynamics: Ocular Inflammation and Pain market drivers and Ocular Inflammation and Pain market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Ocular Inflammation and Pain Unmet Needs, KOL's views, Analyst's views, Ocular Inflammation and Pain Market Access and Reimbursement

To know more about Ocular Inflammation and Pain companies working in the treatment market, visit @ Ocular Inflammation and Pain Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/ocular-inflammation-and-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Ocular Inflammation and Pain Market Report Introduction
2. Executive Summary for Ocular Inflammation and Pain
3. SWOT analysis of Ocular Inflammation and Pain
4. Ocular Inflammation and Pain Patient Share (%) Overview at a Glance
5. Ocular Inflammation and Pain Market Overview at a Glance
6. Ocular Inflammation and Pain Disease Background and Overview
7. Ocular Inflammation and Pain Epidemiology and Patient Population
8. Country-Specific Patient Population of Ocular Inflammation and Pain
9. Ocular Inflammation and Pain Current Treatment and Medical Practices
10. Ocular Inflammation and Pain Unmet Needs
11. Ocular Inflammation and Pain Emerging Therapies
12. Ocular Inflammation and Pain Market Outlook
13. Country-Wise Ocular Inflammation and Pain Market Analysis (2019-2032)
14. Ocular Inflammation and Pain Market Access and Reimbursement of Therapies
15. Ocular Inflammation and Pain Market Drivers
16. Ocular Inflammation and Pain Market Barriers
17. Ocular Inflammation and Pain Appendix
18. Ocular Inflammation and Pain Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Ocular Inflammation and Pain Pipeline https://www.delveinsight.com/report-store/ocular-inflammation-and-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Ocular Inflammation and Pain Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Ocular Inflammation and Pain market. A detailed picture of the Ocular Inflammation and Pain pipeline landscape is provided, which includes the disease overview and Ocular Inflammation and Pain treatment guidelines.
Latest Reports by DelveInsight

Monkeypox Market https://www.delveinsight.com/report-store/monkeypox-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Monkeypox Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Monkeypox, historical and forecasted epidemiology as well as the Monkeypox market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Pars Planitis Market
https://www.delveinsight.com/report-store/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Pars Plantis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pars Plantis, historical and forecasted epidemiology as well as the Pars Plantis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products

Typhoid Market https://www.delveinsight.com/report-store/typhoid-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Typhoid Fever, historical and forecasted epidemiology as well as the Typhoid Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market https://www.delveinsight.com/report-store/zika-virus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Opioid Use Disorder Market https://www.delveinsight.com/report-store/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Opioid Use Disorder (OUD) - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Opioid Use Disorder (OUD), historical and forecasted epidemiology as well as the Opioid Use Disorder (OUD) market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ocular Inflammation and Pain Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Visiox Pharma LLC, Sun Pharma/InSite Vision, Formosa Pharmaceuticals, Inc., Surface Pharmaceuticals, Inc. here

News-ID: 3137658 • Views:

More Releases from DelveInsight Business Research

Alzheimer's Disease Market Poised for Growth by 2032, Projects DelveInsight | Eisai, Biogen, Changchun Huayang High-tech Co., Roche, vTv Therapeutics, AZTherapies, Cerecin, Neurotrope, Lyndra, AC Immune, INmune Bio, Cassava Sciences, EIP Pharma, Neuraly,
Alzheimer's Disease Market Poised for Growth by 2032, Projects DelveInsight | Ei …
(Albany, USA) DelveInsight's "Alzheimer's Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Alzheimer's Disease, historical and forecasted epidemiology as well as the Alzheimer's Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Alzheimer's Disease market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Alzheimer's Disease
Rett Syndrome Market Poised for Growth by 2032, Projects DelveInsight | Featuring Anavex Life Sciences, Vyant Bio, Taysha GeneTherapies, AMO Pharma, Numedicus Limited
Rett Syndrome Market Poised for Growth by 2032, Projects DelveInsight | Featurin …
(Albany, USA) DelveInsight's "Rett Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Rett Syndrome, historical and forecasted epidemiology as well as the Rett Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Rett Syndrome market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Rett Syndrome
Chronic Idiopathic Urticaria Market Anticipates Growth by 2032, Predicts DelveInsight | Roche, Teva Pharmaceuticals, Sanofi, Pfizer, Mylan, GSK, Novartis, Merck, Eli Lilly, Bayer G4A, AstraZeneca, AbbVie, Celldex Therapeutics, Allakos, and Novan
Chronic Idiopathic Urticaria Market Anticipates Growth by 2032, Predicts DelveIn …
(Albany, USA) DelveInsight's "Chronic Idiopathic Urticaria Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Idiopathic Urticaria, historical and forecasted epidemiology as well as the Chronic Idiopathic Urticaria market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Chronic Idiopathic Urticaria market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and
PreDiabetes Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | NanoPrecision Medical, Caelus Health, Inversago Pharma Inc., Haisco Pharma
PreDiabetes Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, PreDiabetes pipeline constitutes 15+ key companies continuously working towards developing 15+ PreDiabetes treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "PreDiabetes Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the PreDiabetes Market. The PreDiabetes Pipeline report embraces in-depth commercial

All 5 Releases


More Releases for Ocular

Developments in Gene Therapy for Ocular Diseases
The Ophthalmic drugs industry continues to expand year on year, with an ageing population there is continual demand for advancements in ophthalmic treatments. This year's Ophthalmic Drugs Conference will have a key focus on gene therapy and artificial intelligence with developments on the latest drug pipelines and clinical trials. The conference will convene on 21 - 22 November 2022 in London, UK, this year attendees will hear from industry giants about
Advancement In Ocular Surgery And New Launches Of Ocular Devices Are Expected To …
The Global Ocular Surgery Market, by device type (Cataract surgery devices, Glaucoma surgery devices, and Vitrectomy surgery devices) and region was valued at US$ 1,517.5 million in 2017 and is projected to exhibit a CAGR of 7.2% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Growing aging population and high incidence rate of diabetes coupled with technological advancement are drivers fueling growth
Global Ocular Drug Delivery Technology Market 2017 – 2025 : Attractiveness, An …
Researchmoz added Most up-to-date research on "Ocular Drug Delivery Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its huge collection of research reports. Ocular Drug Delivery Technology Market: Overview This report on the Global Ocular Drug Delivery Technology market analyzes the current and future scenario of the global market. Rise in private and public funding for R&D of novel drug delivery technologies, increase in
Ocular Hypertension - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Ocular Hypertension - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Pipeline Review, H2 2017, provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous humor
Ocular Drug Delivery Technology Market grows with increasing preference among pa …
Global Ocular Drug Delivery Technology Market: Overview The top three players in the global ocular drug delivery technology market hold more than 50.0% share in it. This makes the competitive landscape consolidated. The topnotch players have climbed to the top owing to their broad range of topical ocular drug products. A noticeable trend in the global ocular drug delivery technology market is the small and large regional players collaborating with
Ocular Hypertension-Pipeline Review H2 2017
ReportsWeb.com has announced the addition of the “Ocular Hypertension-Pipeline Review H2 2017” this report provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous humor does not flow through the trabecular meshwork properly, fluid pressure in the eye builds up, causing ocular hypertension. There are no symptoms with ocular hypertension. Risk factors include